# Avixgen Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/avixgen-co

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.avixgen.com
- Total disclosed funding: $14M
- Latest round: Series B (Jun 22, 2018)
- Investors on record: 6

## About

Established in 2000 and based in Seoul, South Korea, Avixgen is a biotech company specialised in technologues in the biomedical field. In September 2019, Avixgen raised KRW 10.6 billion in pre-IPO funding from new investor Renaissance Asset Management.

## Funding rounds

- Series B, Jun 22, 2018, $9M — Korea Investment & Securities, Hyundai Venture Investment, HB Investment, WONIK Investment Partners
- Series A, Nov 27, 2015, $5.2M — Hyundai Venture Investment, LB Investment, HYUNDAI M Partners Co., Ltd.

## Investors

- Hyundai Venture Investment (https://capitalatlas.ai/funds/hyundai-venture-investment) — Series A, Series B
- LB Investment (https://capitalatlas.ai/funds/lb-investment) — Series A
- HYUNDAI M Partners Co., Ltd. — Series A
- Korea Investment & Securities (https://capitalatlas.ai/funds/korea-investment-securities) — Series B
- HB Investment (https://capitalatlas.ai/funds/hb-investment) — Series B
- WONIK Investment Partners (https://capitalatlas.ai/funds/wonik-investment-partners) — Series B